성균관대 약학대학 사회약학연구실

Cost-effectiveness analysis of tolvaptan for hyponatreamia in South Korea

2012 | 게재지명 : ISPOR 15th Annual European Congress | 발표기관 : ISPOR

Cost-effectiveness analysis of Palivizumab with risk factors for respiratory syncytial virus prevent

2012 | 게재지명 : ISPOR 15th Annual European Congress | 발표기관 : ISPOR

Government policy on reimbursement and pricing in South Korea

2012 | 게재지명 : International Health Economics Conference | 발표기관 : ISPOR Hong Kong Chapter

Issues on utility in the revised pe guideline of korea

2012 | 게재지명 : ISPOR 5th Asia-Pacific Conference | 발표기관 : ISPOR

How to adjust pharmaco-economics to value a new drug fairly?

2012 | 게재지명 : ISPOR 5th Asia-Pacific Conference | 발표기관 : ISPOR